Oakworth Capital, Inc. Bristol Myers Squibb CO Transaction History

Oakworth Capital, Inc.

$1.44 Billion
Q3 2024

A detailed history of Oakworth Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oakworth Capital, Inc. holds 7,488 shares of BMY stock, worth $431,907. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,488

Previous 7,637 1.95%

Holding current value

$431,907

Previous $317,000 22.08%

% of portfolio

0.03%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$39.66 - $51.75 $5,909 - $7,710	-149 Reduced 1.95%	7,488 $387,000
Q2 2024 Jul 19, 2024	BUY	$40.25 - $52.99 $4,628 - $6,093	115 Added 1.53%	7,637 $317,000
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $88,427 - $100,259	-1,843 Reduced 19.68%	7,522 $407,000
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $4,411 - $5,264	-91 Reduced 0.96%	9,365 $480,000
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $10,709 - $11,975	-185 Reduced 1.92%	9,456 $548,000
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $22,043 - $24,476	-346 Reduced 3.46%	9,641 $616,000
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $31,146 - $35,327	-474 Reduced 4.53%	9,987 $692,000
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $81,491 - $96,497	-1,190 Reduced 10.21%	10,461 $752,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $11,982 - $13,196	-165 Reduced 1.4%	11,651 $897,000
Q1 2022 Apr 11, 2022	BUY	$61.48 - $73.72 $70,148 - $84,114	1,141 Added 10.69%	11,816 $863,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $1,448 - $1,688	27 Added 0.25%	10,675 $666,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $25,265 - $29,595	-427 Reduced 3.86%	10,648 $630,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $52,375 - $57,037	-846 Reduced 7.1%	11,075 $740,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $65,926 - $74,148	1,111 Added 10.28%	11,921 $753,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $53,929 - $61,111	-934 Reduced 7.95%	10,810 $671,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $228,763 - $267,447	4,173 Added 55.12%	11,744 $690,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $18,096 - $26,297	-390 Reduced 4.9%	7,571 $422,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $10,678 - $13,929	217 Added 2.8%	7,961 $508,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $187,717 - $222,566	-4,389 Reduced 36.17%	7,744 $393,000
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $2,186 - $2,417	-49 Reduced 0.4%	12,133 $550,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $90,498 - $117,354	1,856 Added 17.97%	12,182 $633,000
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $18,267 - $20,604	331 Added 3.31%	10,326 $641,000
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $50,782 - $63,294	1,005 Added 11.18%	9,995 $554,000
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $101,025 - $116,300	-1,686 Reduced 15.79%	8,990 $469,000
Q4 2017 Jan 22, 2018	SELL	$59.94 - $65.35 $34,345 - $37,445	-573 Reduced 5.09%	10,676 $675,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $621,282 - $717,011	11,249	11,249 $680,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Bristol Myers Squibb CO Transaction History